Hyperkalemia Global Clinical Trials Review, H1, 2014

GlobalData
April 30, 2014
112 Pages - GLDATA18039
$2,500.00

Summary

GlobalData's clinical trial report, “Hyperkalemia Global Clinical Trials Review, H1, 2014" provides data on the Hyperkalemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hyperkalemia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hyperkalemia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

'

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Hyperkalemia 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Clinical Trials by G7 Countries: Proportion of Hyperkalemia to Metabolic Disorders Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Hyperkalemia to Metabolic Disorders Clinical Trials 16
Clinical Trials by Phase in E7 Countries 17
Clinical Trials in E7 Countries by Trial Status 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Clinical Trials by End Point Status 22
Unaccomplished Trials of Hyperkalemia 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Hyperkalemia Therapeutics Clinical Trials 27
Prominent Drugs 28
Latest Clinical Trials News on Hyperkalemia 29
Mar 25, 2014: ZS Pharma Announces Start of Enrollment of Phase 3 Extended Dosing Study of ZS-9 in Patients with Hyperkalemia 29
Feb 04, 2014: Relypsa Completes Enrollment of Phase 1 Onset-of-Action Study for Patiromer 29
Jan 13, 2014: ZS Pharma Announces Positive Results From the Extended Treatment Phase of Its Phase 3 Trial of ZS-9 in Patients With Hyperkalemia 30
Jan 13, 2014: Relypsa Provides Corporate Update 31
Nov 09, 2013: ZS Pharma Announces Positive Top-Line Results of Phase 3 Trial of ZS-9 in Patients with Hyperkalemia 32
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
ZS Pharma, Inc. 34
Clinical Trial Overview of ZS Pharma, Inc. 34
Relypsa, Inc. 35
Clinical Trial Overview of Relypsa, Inc. 35
Clinical Trial Overview of Top Institutes / Government 36
Shonankamakura General Hospital 36
Clinical Trial Overview of Shonankamakura General Hospital 36
South Asian Clinical Toxicology Research collaboration 37
Clinical Trial Overview of South Asian Clinical Toxicology Research collaboration 37
Dalian Medical University 38
Clinical Trial Overview of Dalian Medical University 38
Maisonneuve-Rosemont Hospital 39
Clinical Trial Overview of Maisonneuve-Rosemont Hospital 39
The University of Texas Health Science Center at San Antonio 40
Clinical Trial Overview of The University of Texas Health Science Center at San Antonio 40
Medical University of Vienna 41
Clinical Trial Overview of Medical University of Vienna 41
Hadassah Medical Organization 42
Clinical Trial Overview of Hadassah Medical Organization 42
Five Key Clinical Profiles 43
Appendix 110
Abbreviations 110
Definitions 110
Research Methodology 111
Secondary Research 111
About GlobalData 112
Contact Us 112
Disclaimer 112
Source 112

List of Tables
Hyperkalemia Therapeutics, Global, Clinical Trials by Region, 2014* 6
Hyperkalemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Hyperkalemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Hyperkalemia Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9
Hyperkalemia Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 10
Hyperkalemia Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Hyperkalemia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 12
Proportion of Hyperkalemia to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014* 13
Hyperkalemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Hyperkalemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Hyperkalemia to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014* 16
Hyperkalemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 17
Hyperkalemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 18
Hyperkalemia Therapeutics, Global, Clinical Trials by Phase, 2014* 19
Hyperkalemia Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 20
Hyperkalemia Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Hyperkalemia Therapeutics Clinical Trials, Global, by End Point Status, 2014* 22
Hyperkalemia Therapeutics, Global, Terminated Clinical Trials, 2014* 23
Hyperkalemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 24
Hyperkalemia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 25
Hyperkalemia Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 26
Hyperkalemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 27
Hyperkalemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 28
Hyperkalemia Therapeutics Clinical Trials Market, Global, Clinical Trials by ZS Pharma, Inc., 2014* 34
Hyperkalemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Relypsa, Inc., 2014* 35
Hyperkalemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Shonankamakura General Hospital, 2014* 36
Hyperkalemia Therapeutics Clinical Trials Market, Global, Clinical Trials by South Asian Clinical Toxicology Research collaboration, 2014* 37
Hyperkalemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Dalian Medical University, 2014* 38
Hyperkalemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Maisonneuve-Rosemont Hospital, 2014* 39
Hyperkalemia Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas Health Science Center at San Antonio, 2014* 40
Hyperkalemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2014* 41
Hyperkalemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Hadassah Medical Organization, 2014* 42

List of Figures
Hyperkalemia Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Hyperkalemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Hyperkalemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Hyperkalemia Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 9
Hyperkalemia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 10
Hyperkalemia Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 11
Proportion of Hyperkalemia to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014* 13
Hyperkalemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Hyperkalemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Hyperkalemia to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014* 16
Hyperkalemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 17
Hyperkalemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 18
Hyperkalemia Therapeutics, Global, Clinical Trials by Phase (%), 2014* 19
Hyperkalemia Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 20
Hyperkalemia Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Hyperkalemia Therapeutics Clinical Trials, Global, by End Point Status, 2014* 22
Hyperkalemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 24
Hyperkalemia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 25
Hyperkalemia Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 26
Hyperkalemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 27
Hyperkalemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 28
GlobalData Methodology 111

$2,500.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

info@LMRreports.com
+1 212 564 2838
+1 212 564 8133 fax

Custom Research

Need a custom report
tailored to your goals and budget? 

E-mail us your project outline
or call Client Services to speak
with your industry analyst.

info@LMRreports.com
+1 212 564 2838
+1 212 564 8133 fax

Discount Codes

Request Discount Codes
for reports of interest to you.

info@LMRreports.com
+1 212 564 2838
+1 212 564 8133 fax